A unique rodent model of cardiometabolic risk associated with the metabolic syndrome and polycystic ovary syndrome.
Shi, Danni; Dyck, Michael K; Uwiera, Richard R E; Russell, Jim C; Proctor, Spencer D; Vine, Donna F.
; 150(9): 4425-36, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19470707
Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis.
Increased adipsin is associated with carotid intima media thickness and metabolic disturbances in polycystic ovary syndrome.
Can the source of hyperandrogenism in adolescents with polycystic ovary syndrome predict metabolic phenotype?
Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women.
Identification of the key pathways and genes related to polycystic ovary syndrome using bioinformatics analysis.
Analysis on endocrine and metabolic features of different phenotypes of polycystic ovary syndrome patients.
Leukaemia inhibitory factor in serum and follicular fluid of women with polycystic ovary syndrome and its correlation with IVF outcome.
High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome.
Increased insulin-like growth factor-1 in relation to cardiovascular function in polycystic ovary syndrome: friend or foe?
A novel method to demonstrate that pregnant women with polycystic ovary syndrome hyper-expose their fetus to androgens as a possible stepping stone for the developmental theory of PCOS. A pilot study.